← All stocks

GILD vs GSK

Gilead Sciences Inc. Common Stock vs GSK plc American Depositary Shares (Each representing two Ordinary Shares). Side-by-side ACCE scores, valuation, profitability, and growth.

ACCE scores
GILD
GSK
Composite score
Out of 100
64
63
Growth
76
28
Value
40
81
Quality
55
88
Momentum
83
54
Valuation
GILD
GSK
Price
150.56
51.08
Market cap
186.13B
100.58B
Trailing P/E
0.00
15.94
Forward P/E
15.29
9.67
EV / EBITDA
116.03
9.34
Dividend yield
2.1%
3.6%
Profitability
GILD
GSK
ROE
-20.7%
33.4%
Net margin
-10.6%
14.5%
Debt / equity
1.10
1.03
Free cash flow
9.46B
5.82B
Growth
GILD
GSK
Revenue growth (YoY)
10.2%
5.3%
Earnings growth (YoY)
54.8%
-69.5%
Analyst target
158.15
59.33
See full analysis